Netskope Inc
NTSK Nasdaq Services-Prepackaged Software Financials FY2024βFY2026
What Netskope Inc does
No business description yet.
- Legal name
- Netskope Inc
- Fiscal year ends
- January 31, 2026
- Latest annual report
- 10-K Β· Mar 31, 2026
- Accession Β· CIK
- 0001193125-26-135011
0002063196
Revenue and margins
Netskope Inc had $709M of revenue in fiscal 2026, up 31.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $15.2M in fiscal 2026, 2.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Netskope Inc returned $0.6M to shareholders in fiscal 2026, 4% of free cash flow. The diluted share count rose 119.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Netskope Inc can carry it.
| Fiscal year end | FY24 | FY25 | FY26 |
|---|---|---|---|
| Cash and short-term investments | β | $247M | $1.2B |
| Current ratio | β | 1.0x | 2.1x |
| Quick ratio | β | 1.0x | 2.1x |
| Total assets | β | $859M | $1.8B |
| Total liabilities | β | $1.3B | $1.6B |
| Shareholders' equity | β$257M | β$486M | $195M |
| Net debt (β = net cash) | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 5 | 5 / 8 |
| Accruals ratio | β | β28.4% | β54.5% |
| Altman Z'' | β | β9.77 | β4.34 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY24 | FY25 | FY26 |
|---|---|---|---|
| Income statement | |||
| Revenue | $407M | $538M | $709M |
| Gross profit | $243M | $348M | $483M |
| Research and development | $224M | $254M | $509M |
| Operating income | β$313M | β$256M | β$653M |
| Pretax income | β$338M | β$350M | β$668M |
| Income tax | $6.8M | $4.2M | $11.3M |
| Net income | β$345M | β$355M | β$679M |
| Diluted EPS | β$3.77 | β$3.64 | β$3.18 |
| Diluted shares | 0.09B | 0.10B | 0.21B |
| Cash flow | |||
| Cash from operations | β$167M | β$111M | $38.1M |
| Capital expenditure | $30.6M | $33.7M | $22.9M |
| Free cash flow | β$198M | β$144M | $15.2M |
| Depreciation and amortization | $28.2M | $31.7M | $30.1M |
| Stock-based compensation | $61.0M | $50.8M | $516M |
| Acquisitions | $13.6M | $2.5M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.6M |
| Dividends and buybacks | $0.0M | $0.0M | $0.6M |
| Balance sheet | |||
| Cash and short-term investments | β | $247M | $1.2B |
| Current assets | β | $528M | $1.4B |
| Current liabilities | β | $527M | $682M |
| Inventory | β | $5.8M | $4.9M |
| Property and equipment, net | β | $99.5M | $93.9M |
| Goodwill | $57.2M | $61.1M | $61.1M |
| Intangible assets | β | $37.2M | $21.4M |
| Total assets | β | $859M | $1.8B |
| Total liabilities | β | $1.3B | $1.6B |
| Shareholders' equity | β$257M | β$486M | $195M |
| Margins | |||
| Gross margin | 59.8% | 64.6% | 68.1% |
| Operating margin | β76.9% | β47.5% | β92.0% |
| EBITDA margin | β69.9% | β41.6% | β87.8% |
| Net margin | β84.8% | β65.9% | β95.8% |
| FCF margin | β48.6% | β26.8% | 2.1% |
| Returns | |||
| Return on capital employed | β | β77.1% | β59.8% |
| Return on assets | β | β41.3% | β51.6% |
| Return on tangible equity | β | β | β606.4% |
| Growth | |||
| Revenue growth | β | 32.3% | 31.7% |
| Share count change | β | 6.7% | 119.3% |
| Financial health | |||
| Current ratio | β | 1.0x | 2.1x |
| Quick ratio | β | 1.0x | 2.1x |
| Capital allocation | |||
| Capex / revenue | 7.5% | 6.3% | 3.2% |
| Stock comp / revenue | 15.0% | 9.4% | 72.8% |
| Payouts / FCF | β | β | 3.7% |
| Quality scores | |||
| Piotroski F-score | β | β | 5.0 |
| Altman Z'' | β | β9.8 | β4.3 |
| Accruals ratio | β | β28.4% | β54.5% |
Source: SEC EDGAR XBRL filings (CIK 0002063196). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.